1
Clinical Trials associated with GPC3/Mesothelin-CAR-γδT Cells(Second Affiliated Hospital of Guangzhou Medical University)GPC3/Mesothelin Targeted CAR-γδT for Immunotherapy of Solid Cancer: Phase I Clinical Trial
The third generation of GPC3/mesothelin targeted CAR-γδT cells have been constructed and their anti-cancer function has been verified by multiple in vitro and in vivo studies. Clinical studies will be performed to test anti-cancer function of the CAR-γδT cells for immunotherapy of human cancer patients with GPC3 or Mesothelin expressions. In this phase I study, the safety, tolerance, and preliminary efficacy of the GPC3/Mesothelin-CAR-γδT cell immunotherapy on human cancers will firstly be evaluated.
100 Clinical Results associated with GPC3/Mesothelin-CAR-γδT Cells(Second Affiliated Hospital of Guangzhou Medical University)
100 Translational Medicine associated with GPC3/Mesothelin-CAR-γδT Cells(Second Affiliated Hospital of Guangzhou Medical University)
100 Patents (Medical) associated with GPC3/Mesothelin-CAR-γδT Cells(Second Affiliated Hospital of Guangzhou Medical University)
100 Deals associated with GPC3/Mesothelin-CAR-γδT Cells(Second Affiliated Hospital of Guangzhou Medical University)